2m 2m 2m 2m 2m 2m 2m
Corvus Pharmacet (CRVS)
NASDAQ
$13.30+$0.04 (+0.33%)
Price as of Aug 03, 2026 8:30 AM EDT- $1.1BMarket Cap
- 223.41%1-Year Change
- BiotechnologyIndustry
Corvus Pharmacet (CRVS)
$13.30+$0.04 (+0.33%)
Earnings Score
Valuation | CRVS | vs History | vs S&P 500 |
|---|---|---|---|
Profitability | -0 | ||
Growth | -0 | ||
Low Earnings Volatility | 0 |
Momentum Score
Valuation | CRVS | vs History | vs S&P 500 |
|---|---|---|---|
3-Month Momentum | -5.51% | ||
12-Month Momentum | 253.96% | ||
3-Month Risk Adjusted Momentum | -19.02% | ||
12-Month Risk Adjusted Momentum | 142.05% |
True Yield
Valuation | CRVS | vs History | vs S&P 500 |
|---|---|---|---|
Dividend Yield | N/A | ||
Net Buyback Yield | N/A | ||
Net Debt Paydown Yield | N/A |
Financial Health Score
Valuation | CRVS | vs History | vs S&P 500 |
|---|---|---|---|
Ohlson's O-Score | 2 |